Australia - English - Department of Health (Therapeutic Goods Administration)

bioconnexus australia pty ltd - 43186 - exudate-absorbent dressing, hydrophilic-gel - assists in wound healing by absorbing exudate in wounds (e.g., ulcers, burns, surgical wounds, lacerations, abrasions) for minimal wound maceration, allowing wound debridement, and creating a moist wound-healing environment.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: povidone; calcium hydrogen phosphate dihydrate; hypromellose; magnesium stearate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - posaconazole, quantity: 100 mg - tablet, modified release - excipient ingredients: hypromellose acetate succinate; microcrystalline cellulose; hyprolose; croscarmellose sodium; silicon dioxide; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - posaconazole sandoz (posaconazole) is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older:,? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole sandoz is also indicated for the prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - memantine hydrochloride, quantity: 5 mg (equivalent: memantine, qty 4.15 mg) - tablet, film coated - excipient ingredients: purified talc; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease (see pharmacology; precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - memantine hydrochloride, quantity: 5 mg (equivalent: memantine, qty 4.15 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; purified talc; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease (see pharmacology; precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; purified water; magnesium stearate; hyprolose; hypromellose; titanium dioxide; iron oxide yellow; macrogol 4000 - olmertan is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: purified water; lactose monohydrate; hyprolose; microcrystalline cellulose; hypromellose; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 4000 - olmertan is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - ascorbic acid,calcium carbonate,colecalciferol,cupric sulfate,cyanocobalamin,d-alpha-tocopheryl acid succinate,ferrous fumarate,folic acid,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine hydrochloride,zinc oxide -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - emtricitabine,tenofovir disoproxil maleate -

United States - English - NLM (National Library of Medicine)

enaltus inc - octinoxate 7.5% octisalate 5.0% octocrylene 10% oxybenzone 6.0%, sunscreen - biocorneum is a unique scar therapy providing a patented silicone gel to help prevent abnormal scar formation with high protection sunscreen agents.